Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039178
Filing Date
2023-08-07
Accepted
2023-08-07 17:21:01
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20230630.htm   iXBRL 10-Q 3105976
2 EX-10.1 axsm-ex10_1.htm EX-10.1 83584
3 EX-31.1 axsm-ex31_1.htm EX-31.1 18647
4 EX-31.2 axsm-ex31_2.htm EX-31.2 18461
5 EX-32.1 axsm-ex32_1.htm EX-32.1 8547
6 EX-32.2 axsm-ex32_2.htm EX-32.2 8533
  Complete submission text file 0000950170-23-039178.txt   11684982

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20230630_pre.xml EX-101.PRE 462911
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20230630_def.xml EX-101.DEF 264687
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20230630_lab.xml EX-101.LAB 619604
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20230630.xsd EX-101.SCH 82986
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axsm-20230630_cal.xml EX-101.CAL 62193
86 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20230630_htm.xml XML 2172113
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 231148569
SIC: 2834 Pharmaceutical Preparations